Eco-efficiency assessment of disease-infected shrimp farming in Mexico using environmental impact assessment tools.

Mexico ranks second in shrimp (Litopenaeus vannamei) production of in Latin America with significant annual growth, however, during 2011 shrimp production fell by almost 50 % due to the presence of the white spot syndrome virus (WSSV). In this context, a life cycle analysis (LCA) and data envelopment analysis (DEA) were performed on 76 commercial farms severely affected by the presence of WSSV in northwestern Mexico. The application of this combined methodology allowed a detailed quantification of different environmental impact categories. During the presence of WSSV, there was a negative effect on the feed conversion ratio (FCR) (>40 %), higher consumption of seawater (38 %), and energy (38 %). Consequently, operational outputs related to the discharge of nitrogen and phosphorus increased by 60 and 57 %, respectively. Similarly, CO2 emissions, increased by 38 % relative to a typical year of production. Overall, the main critical points in the impact categories analyzed are related to food (98 %), use of diesel (23 %), and rearing (24 %), dominating pollutants emissions in all categories. Consequently, an improvement scenario was evaluated related to innovation in the formulation of foods supplied with immunostimulants, which confer protection against pathogenic microorganisms. This scenario lead to a reduction environmental impact of about 82 %. The results of this analysis will be a useful resource in the design of mitigation strategies with innovation processes that allow maintaining yields for shrimp producers in this region and at the same time reduce the environmental impacts generated.

Socio-Economic Development and Mental Health: Case Study of the Spanish Region of Aragon (2010-20).

Introduction: Considering health as a cross-cutting element of all public policies leads to rethinking its interactions with the environment in which people live. The collection of large volumes of data by public administrations offers the opportunity to monitor and analyze the possible associations between health and territory. The increase in the incidence and prevalence of mental health diseases, particularly depression, justifies the need to develop studies that seek to identify links with the socioeconomic and environmental setting. Objective: The objective of this study is to explain the behavior of the depression in a mediterranean region of Northeastern Spain from an ecological and diachronic perspective. Methods: We conducted a correlation and multivariate logistic regression analysis to identify explanatory factors of the prevalence of depression in 2010 and 2020 and in the variation rate. Potential explanatory factors are related to the socioeconomic status and to the territorial development level. Results: The regression models retained both socioeconomic and territorial development variables as predictors of the prevalence in both years and in the variation rate. Rural areas seem to play a protective role against the prevalence. Conclusion: It is under the territorial prism that epidemiological studies could offer useful guidelines for proactive decision-making. The integration of data on diseases and territory must be considered when developing policies for the creation of healthier environments and for directing health services with more specific resources to where they may be needed.

Eco-sustainable passive treatment for mine waters: Full-scale and long-term demonstration.

This paper tries to analyse the technical and economic performance of a full-scale passive Disperse Alkaline Substrate (DAS) treatment plant steadily operating for 28 months (840 days) to treat extremely acidic and metal rich mine waters in the Iberian Pyrite Belt (SW Spain). For the first time, an economic evaluation of this technology and its comparison with other passive treatments is reported. During this period, around 56,000 m3 of mine waters have been treated, without significant clogging or exhaustion of the alkaline substrate. The efficiency of the system is demonstrated by a significant decrease in the average net acidity (from 2005 to -43 mg/L as CaCO3 equivalent) and the total elimination of Al, Cu, REY, Zn, As, Cr, Mo, V, Cd, Pb, Co and other trace metals. Water quality of the treated output discharge meets the threshold values for irrigation and drinking standards, except for Fe, Mn and sulphate. The accumulation of elements of economic interest in the waste (e.g., 32 t of Fe, 6.1 t of Al, 0.8 t of Cu, 0.8 t of Zn, 39.4 kg of REE, 20 kg of Co or 1 kg of Sc), easily extractable with diluted acids, may turn a hazardous waste into a valuable resource. The benefits associated with the revalorization of this metal-rich waste could reach a total of 27478 USD, but is more reliably estimated to be around 8243 USD due to technologic limitations. This benefit would help to defray the maintenance costs (8428 €) and make DAS an economically self-sustainable treatment. The annual treatment cost for DAS was 0.27 €/m3, being the lowest value found among other reported conventional passive schemes, and from 8 to 12 times lower compared to active technologies. The results obtained prove that the DAS technology is the most technically and economically sustainable way to decontaminate acid and metal-rich mine waters in abandoned mines.

[Social determinants and the Sustainable Development Goals' tuberculosis target in the AmericasDeterminantes sociais e a meta para a tuberculose dos Objetivos de Desenvolvimento Sustentável nas Américas]. / Determinantes sociales y meta de tuberculosis en los Objetivos de Desarrollo Sostenible en las Américas.

OBJECTIVE: Determine patterns of tuberculosis (TB) incidence indicators and number of deaths from TB within the framework of target 3.3 of the Sustainable Development Goals (SDGs) and their correlation with social determinants. METHODS: Ecological study methodology was used, in which the population is the unit of analysis. Social determinants were analyzed using a negative binomial regression model and strength of association. RESULTS: In the Americas, there was an average annual reduction in the TB incidence rate of 0.3% from 2009 to 2018; however, from 2015 to 2018, the rate increased, from 27.6 to 28.8 per 100,000 population. With regard to social determinants, the groups of countries with the lowest human development index (HDI) and gross domestic product (GDP) have a higher incidence of TB. TB risk in the country with the lowest HDI is six times that of the country with the highest HDI. CONCLUSIONS: At the current rate of reduction in the incidence rate and number of deaths from TB, the Region of the Americas will not meet the targets in the SDGs and in the End TB Strategy. Rapid implementation and expansion of interventions for TB prevention and control are required to attain the targets. This involves, among other actions, reducing access barriers to diagnosis and treatment and strengthening initiatives to address social determinants.

OBJETIVO: Determinar o comportamento dos indicadores de incidência da tuberculose (TB) e o número de mortes por TB no quadro da meta 3.3 dos Objetivos de Desenvolvimento Sustentável (ODS) e sua correlação com os determinantes sociais. MÉTODOS: Utilizamos uma metodologia de estudo ecológico, na qual a unidade de análise é a população. Para a análise dos determinantes sociais, utilizamos o modelo de regressão binomial negativo e a avaliamos a força das associações. RESULTADOS: Nas Américas, observou-se uma redução anual média na taxa de incidência de TB de 0,3% entre 2009 e 2018; entretanto, de 2015 a 2018 houve um aumento, de 27,6 para 28,8 por 100.000 habitantes. Com relação aos determinantes sociais, os grupos de países com índice de desenvolvimento humano (IDH) e produto interno bruto (PIB) mais baixos apresentam uma maior incidência de TB. O risco de TB no país com o menor IDH é seis vezes maior que no país com o maior IDH. CONCLUSÕES: Se mantido o ritmo atual de redução na taxa de incidência e no número de mortes por TB, a Região das Américas não alcançará as metas propostas nos ODS e na Estratégia pelo Fim da Tuberculose. É necessária uma implementação e expansão mais rápida das intervenções de prevenção e controle da TB para alcançar este objetivo. Isto implica, entre outras ações, reduzir as barreiras de acesso ao diagnóstico e tratamento e fortalecer as iniciativas que abordam os determinantes sociais.

Determinantes sociales y meta de tuberculosis en los Objetivos de Desarrollo Sostenible en las Américas

[RESUMEN]. Objetivo. Determinar el comportamiento de los indicadores de incidencia de tuberculosis (TB) y número de muertes por TB en el marco de la meta 3.3 de los Objetivos de Desarrollo Sostenible (ODS) y su correlación con los determinantes sociales. Métodos. Se utilizó una metodología de estudio ecológico, en el cual la unidad de análisis es la población. Para el análisis de los determinantes sociales, se hizo uso del modelo de regresión binomial negativo y la fuerza de asociación. Resultados. En las Américas se ha presentado una disminución promedio anual en la tasa de incidencia de TB de 0,3% entre 2009 y 2018; sin embargo, de 2015 a 2018 ha habido un aumento, pasando de 27,6 a 28,8 por 100 000 habitantes. Con respecto a los determinantes sociales, los grupos de países con índice de desarrollo humano (IDH) y producto interno bruto (PIB) más bajos tienen una incidencia de TB más alta. El riesgo de TB en el país con IDH más bajo es seis veces mayor que en el país con IDH más alto. Conclusiones. Al ritmo de la disminución actual de la tasa de incidencia y del número de muertes por TB, la Región de las Américas no alcanzará las metas propuestas en los ODS y en la Estrategia Fin de la TB. Se requiere una implementación y expansión rápidas de las intervenciones en prevención y control de TB para lograrlo. Esto implica, entre otras acciones, reducir las barreras de acceso al diagnóstico y tratamiento y fortalecer las iniciativas para abordar los determinantes sociales.

[ABSTRACT]. Objective. Determine patterns of tuberculosis (TB) incidence indicators and number of deaths from TB within the framework of target 3.3 of the Sustainable Development Goals (SDGs) and their correlation with social determinants. Methods. Ecological study methodology was used, in which the population is the unit of analysis. Social determinants were analyzed using a negative binomial regression model and strength of association. Results. In the Americas, there was an average annual reduction in the TB incidence rate of 0.3% from 2009 to 2018; however, from 2015 to 2018, the rate increased, from 27.6 to 28.8 per 100,000 population. With regard to social determinants, the groups of countries with the lowest human development index (HDI) and gross domestic product (GDP) have a higher incidence of TB. TB risk in the country with the lowest HDI is six times that of the country with the highest HDI. Conclusions. At the current rate of reduction in the incidence rate and number of deaths from TB, the Region of the Americas will not meet the targets in the SDGs and in the End TB Strategy. Rapid implementation and expansion of interventions for TB prevention and control are required to attain the targets. This involves, among other actions, reducing access barriers to diagnosis and treatment and strengthening initiatives to address social determinants.

[RESUMO]. Objetivo. Determinar o comportamento dos indicadores de incidência da tuberculose (TB) e o número de mortes por TB no quadro da meta 3.3 dos Objetivos de Desenvolvimento Sustentável (ODS) e sua correlação com os determinantes sociais. Métodos. Utilizamos uma metodologia de estudo ecológico, na qual a unidade de análise é a população. Para a análise dos determinantes sociais, utilizamos o modelo de regressão binomial negativo e a avaliamos a força das associações. Resultados. Nas Américas, observou-se uma redução anual média na taxa de incidência de TB de 0,3% entre 2009 e 2018; entretanto, de 2015 a 2018 houve um aumento, de 27,6 para 28,8 por 100.000 habitantes. Com relação aos determinantes sociais, os grupos de países com índice de desenvolvimento humano (IDH) e produto interno bruto (PIB) mais baixos apresentam uma maior incidência de TB. O risco de TB no país com o menor IDH é seis vezes maior que no país com o maior IDH. Conclusões. Se mantido o ritmo atual de redução na taxa de incidência e no número de mortes por TB, a Região das Américas não alcançará as metas propostas nos ODS e na Estratégia pelo Fim da Tuberculose. É necessária uma implementação e expansão mais rápida das intervenções de prevenção e controle da TB para alcançar este objetivo. Isto implica, entre outras ações, reduzir as barreiras de acesso ao diagnóstico e tratamento e fortalecer as iniciativas que abordam os determinantes sociais.

[Using Trigger Tool to detect incidents and adverse events in a mutual insurance company that collaborate with the Social Security system]. / Uso del Trigger Tool para la Detección de Incidentes y Eventos Adversos en una Mutua Colaboradora con la Seguridad Social.

OBJECTIVE: To evaluate differences between the detection of incidents or adverse events (I/AE) using a Trigger Tool (TT) and voluntary notification platform (SNEA). METHODS: The study population is the working population attended on an outpatient basis in an Insurance Company ("mutua") from January to September 2016. The cases declared as Incident or Adverse Event (I / AE) were selected through the SNEA (21 cases), according to whether the event has not affected the patient or on the contrary has affected him. On the other hand, 20 clinical histories per month were randomly selected where the TT was applied(180 cases). The 201 clinical histories were reviewed looking for the existence of triggers. The agreement between the SNEA system and the TT was evaluated using proportion of positive agreement (I/EA), proportion of negative agreement (not I/EA) and Kappa index. RESULTS: TT detected I/EA cases in 41.3% of the revisions while the SNEA was 10.3% (p<0.001). The Kappa index showed a low concordance value (Kappa = 0.12), which indicates the small coincidence of I/EA detected by both systems. The proportion of negative agreement was greater than that of positive agreement (74.5% versus 26.9%). The SNEA system detected less I/ EA and above all it deals with fewer incidents. On the contrary, the TT system detected a greater number of I EA and especially EA. CONCLUSIONS: Trigger Tool is a recommended tool for the detection of incidents or adverse events that can complement the one obtained through voluntary notification platform in the reality of a "mutua".

OBJETIVO. Evaluar diferencias entre la detección de incidentes o eventos adversos (I/EA) en una mutua laboral, mediante una herramienta tipo Trigger Tool (TT) y una plataforma de notificación voluntaria (SNEA). MÉTODOS. La población de estudio es la población trabajadora atendida ambulatoriamente en una mutua laboral de Enero a Septiembre del 2016. Se seleccionaron los casos declarados como I/EA según si el evento no ha afectado al paciente o por el contrario le ha afectado, a través del SNEA (n=21 casos). Por otro lado, se seleccionaron aleatoriamente 20 historias clínicas por mes donde se aplicó la herramienta TT (180 casos). Se adaptaron 11 triggers para detectar I/EA. Se revisaron las 201 historias clínicas buscando la existencia de triggers. Se obtuvo la concordancia entre el sistema SNEA y el TT utilizando la proporción de concordancia positiva (I/EA), proporción de concordancia negativa (no I/EA) e índice Kappa. RESULTADOS. TT detectó casos de I/EA en el 41,3% de las revisiones mientras que el SNEA 10,3% (p<0,001). El índice Kappa ofreció un valor de concordancia baja (Kappa=0,12) lo que denota la pequeña coincidencia de sucesos adversos detectados por ambos sistemas. La proporción de concordancia negativa fue mayor que la de concordancia positiva (74,5% frente a un 26,9%). El sistema SNEA detectó menos I/EA y sobre todo se trata de menos incidentes. Por el contrario, el sistema TT detectó mayor número de I/EA y especialmente EA. CONCLUSIONES. Trigger Tool es una herramienta recomendable para la detección de incidentes o eventos adversos que puede complementar la obtenida mediante una plataforma de notificación voluntaria en la realidad de una Mutua laboral.

Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean

[ABSTRACT]. Objective. To inform about the most recent epidemiological trends and integrated programmatic response to tuberculosis (TB) and HIV coinfection in Latin America and the Caribbean (LAC). Methods. A descriptive review analyzed the most relevant indicators on TB/HIV coinfection in 33 countries in LAC with a cross-sectional and time-trend approach. Data were obtained from publicly available databases and analyzed through simple proportions, weighted means, and risk ratios. Results. In LAC, during 2017, 80.8% of TB patients were actively screened for HIV, with a 25.6% increase between 2011 and 2017. In the same year, the proportion of TB patients with HIV-positive status was 11.2%, with a small but progressive reduction of 5% since 2011. The provision of antiretroviral therapy and anti-TB medication among TB/HIV coinfected patients for 2017 was at 60%. Only one-third of people living with HIV had access to isoniazid preventive therapy. Overall, the mortality in the TB/HIV cohort has not changed since 2012, hovering at around 20%. Conclusions. TB/HIV collaborative activities, as the backbone to address TB/HIV coinfection, are being scaled up in LAC and some indicators show a tendency toward improvement; nevertheless, our review shed light on the need to keep strengthening integration of service delivery, joint monitoring and evaluation, and data quality.

[RESUMEN]. Objetivo. Informar sobre las tendencias epidemiológicas más recientes y la respuesta programática integrada frente a la coinfección por tuberculosis (TB) y VIH en América Latina y el Caribe. Métodos. En una revisión descriptiva se analizaron los indicadores más pertinentes sobre la coinfección por TB y VIH en 33 países de América Latina y el Caribe, por medio de un enfoque transversal y de tendencias en el tiempo. Los datos se obtuvieron de bases de datos disponibles públicamente y se analizaron mediante proporciones sencillas, medias ponderadas y cociente de riesgos. Resultados. En el 2017, en América Latina y el Caribe se sometió a 80,8% de los pacientes con TB a un tamizaje activo del VIH, lo que representó un aumento de 25,6% entre el 2011 y el 2017. En ese mismo año, la proporción de pacientes con TB e infección por el VIH fue de 11,2%, lo cual demuestra una pequeña reducción, aunque progresiva, de 5% desde el 2011. El suministro de tratamiento antirretroviral y de fármacos contra la TB a los pacientes con la coinfección en el 2017 fue del 60%. Solo un tercio de las personas con VIH tuvieron acceso al tratamiento preventivo con isoniacida. En términos generales, la tasa de mortalidad de las personas con coinfección por TB y VIH no ha cambiado desde el 2012, y ha permanecido en torno al 20%. Conclusiones. Se está aumentando la escala de las actividades de colaboración entre los servicios de TB y VIH en América Latina y el Caribe, como el tratamiento de base para abordar los casos de coinfección, y algunos indicadores muestran una tendencia positiva. No obstante, nuestra revisión muestra la necesidad de seguir fortaleciendo la integración de la prestación de servicios, las actividades conjuntas de seguimiento y evaluación, y la comprobación de la calidad de los datos.

[RESUMO]. Objetivo. Informar sobre as últimas tendências epidemiológicas e a resposta programática integrada à coinfecção por tuberculose (TB) e HIV na América Latina e Caribe (ALC). Métodos. Uma revisão descritiva analisou os indicadores mais relevantes sobre a coinfecção por TB/HIV em 33 países da ALC, usando uma abordagem transversal e de tendências temporais. Os dados foram obtidos em bases de dados disponíveis publicamente e analisados através de proporções simples, médias ponderadas e razões de risco. Resultados. Na ALC, em 2017, 80,8% dos pacientes com TB realizaram o rastreamento ativo para HIV, o que representou um aumento de 25,6% entre 2011 e 2017. No mesmo ano, a proporção de pacientes com TB com status HIV positivo foi de 11,2%, demonstrando uma pequena redução progressiva de 5% desde 2011. Em 2017, a oferta de terapia antirretroviral e medicação anti-TB aos pacientes coinfectados por TB/HIV foi de 60%. Somente um terço das pessoas que vivem com HIV teve acesso à terapia preventiva com isoniazida. A mortalidade geral na coorte coinfectada por TB/HIV não mudou desde 2012, oscilando em torno de 20%. Conclusões. As atividades colaborativas para TB/HIV, que são a espinha dorsal para combater esta coinfecção, estão sendo ampliadas na ALC, e alguns indicadores mostram uma tendência positiva; no entanto, a nossa revisão destaca a necessidade de continuar fortalecendo a integração da prestação de serviços, as atividades conjuntas de monitoramento e avaliação e a qualidade dos dados.

Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice.

PURPOSE: Several frameworks have been developed to define and quantify the value of oncologic therapies and to support decision making; however, they define treatment value mainly in terms of clinical benefit. As part of its mission to improve oncologic care, the ECO Foundation (Excellence and Quality in Oncology) directed this pilot study aimed at developing a reflective multicriteria decision analysis (MCDA)-based framework for evaluating and positioning oncologic drugs in the clinical setting. METHODS: The framework was developed following Evidence and Value: Impact on Decision-Making methodology, and literature was reviewed to identify relevant criteria. The selected criteria were then presented to a group of experts composed of 9 clinical oncologists who assessed each criterion for inclusion in the framework and suggested modifications in their definition and/or response scale. The framework was tested in 2 case studies (abemaciclib for advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer and TAS-102 for metastatic colorectal cancer) to validate the proposed framework; this was followed by a discussion of the results. RESULTS: Eight of the 15 criteria presented to the experts were included in the framework: disease severity, unmet needs, comparative efficacy, comparative safety/tolerability, treatment intent, comparative treatment cost, comparative other medical costs, and quality of evidence. Framework validation in 2 drug cases resulted in similar value scores, although they were based on different contributing criteria and resulted in different clinical recommendations. CONCLUSION: We developed and validated a reflective MCDA framework for the assessment and positioning of oncologic therapies in Spain. Additional work is needed to create a manual for practical decision making in the clinical setting.

Effects of Mosquito Microbiota on the Survival Cost and Development Success of Avian Plasmodium.

Both intrinsic and extrinsic factors affect the capacity of mosquitoes for the transmission of vector-borne pathogens. Among them, mosquito microbiota may play a key role determining the development of pathogens in mosquitoes and the cost of infections. Here, we used a wild avian malaria-mosquito assemblage model to experimentally test the role of vector microbiota on the cost of infection and their consequences for parasite development. To do so, a cohort of Culex pipiens mosquitoes were treated with antibiotics, including gentamicin sulfate and penicillin-streptomycin, to alter their microbiota, and other cohort was treated with sterilized water as controls. Subsequently, both cohorts were allowed to feed on Plasmodium infected or uninfected house sparrows (Passer domesticus). The antibiotic treatment significantly increased the survival rate of mosquitoes fed on infected birds while this was not the case of mosquitoes fed on uninfected birds. Additionally, a higher prevalence of Plasmodium in the saliva of mosquitoes was found in antibiotic treated mosquitoes than in mosquitoes of the control group at 20 days post exposure (dpe). Analyses of the microbiota of a subsample of mosquitoes at 20 dpe suggest that although the microbiota diversity did not differ between individuals of the two treatments, microbiota in control mosquitoes had a higher number of unique features and enriched in biochemical pathways related to the immune system than antibiotic treated ones. In sum, this study provides support for the role of mosquito microbiota on mosquito survival and the presence of parasite DNA in their saliva.

Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean / Coinfección por tuberculosis y VIH, y actividades de colaboración relacionadas en América Latina y el Caribe / Coinfecção por tuberculose e HIV e atividades colaborativas relacionadas na América Latina e Caribe

ABSTRACT Objective. To inform about the most recent epidemiological trends and integrated programmatic response to tuberculosis (TB) and HIV coinfection in Latin America and the Caribbean (LAC). Methods. A descriptive review analyzed the most relevant indicators on TB/HIV coinfection in 33 countries in LAC with a cross-sectional and time-trend approach. Data were obtained from publicly available databases and analyzed through simple proportions, weighted means, and risk ratios. Results. In LAC, during 2017, 80.8% of TB patients were actively screened for HIV, with a 25.6% increase between 2011 and 2017. In the same year, the proportion of TB patients with HIV-positive status was 11.2%, with a small but progressive reduction of 5% since 2011. The provision of antiretroviral therapy and anti-TB medication among TB/HIV coinfected patients for 2017 was at 60%. Only one-third of people living with HIV had access to isoniazid preventive therapy. Overall, the mortality in the TB/HIV cohort has not changed since 2012, hovering at around 20%. Conclusions. TB/HIV collaborative activities, as the backbone to address TB/HIV coinfection, are being scaled up in LAC and some indicators show a tendency toward improvement; nevertheless, our review shed light on the need to keep strengthening integration of service delivery, joint monitoring and evaluation, and data quality.(AU)

RESUMEN Objetivo. Informar sobre las tendencias epidemiológicas más recientes y la respuesta programática integrada frente a la coinfección por tuberculosis (TB) y VIH en América Latina y el Caribe. Métodos. En una revisión descriptiva se analizaron los indicadores más pertinentes sobre la coinfección por TB y VIH en 33 países de América Latina y el Caribe, por medio de un enfoque transversal y de tendencias en el tiempo. Los datos se obtuvieron de bases de datos disponibles públicamente y se analizaron mediante proporciones sencillas, medias ponderadas y cociente de riesgos. Resultados. En el 2017, en América Latina y el Caribe se sometió a 80,8% de los pacientes con TB a un tamizaje activo del VIH, lo que representó un aumento de 25,6% entre el 2011 y el 2017. En ese mismo año, la proporción de pacientes con TB e infección por el VIH fue de 11,2%, lo cual demuestra una pequeña reducción, aunque progresiva, de 5% desde el 2011. El suministro de tratamiento antirretroviral y de fármacos contra la TB a los pacientes con la coinfección en el 2017 fue del 60%. Solo un tercio de las personas con VIH tuvieron acceso al tratamiento preventivo con isoniacida. En términos generales, la tasa de mortalidad de las personas con coinfección por TB y VIH no ha cambiado desde el 2012, y ha permanecido en torno al 20%. Conclusiones. Se está aumentando la escala de las actividades de colaboración entre los servicios de TB y VIH en América Latina y el Caribe, como el tratamiento de base para abordar los casos de coinfección, y algunos indicadores muestran una tendencia positiva. No obstante, nuestra revisión muestra la necesidad de seguir fortaleciendo la integración de la prestación de servicios, las actividades conjuntas de seguimiento y evaluación, y la comprobación de la calidad de los datos.(AU)

RESUMO Objetivo. Informar sobre as últimas tendências epidemiológicas e a resposta programática integrada à coinfecção por tuberculose (TB) e HIV na América Latina e Caribe (ALC). Métodos. Uma revisão descritiva analisou os indicadores mais relevantes sobre a coinfecção por TB/HIV em 33 países da ALC, usando uma abordagem transversal e de tendências temporais. Os dados foram obtidos em bases de dados disponíveis publicamente e analisados através de proporções simples, médias ponderadas e razões de risco. Resultados. Na ALC, em 2017, 80,8% dos pacientes com TB realizaram o rastreamento ativo para HIV, o que representou um aumento de 25,6% entre 2011 e 2017. No mesmo ano, a proporção de pacientes com TB com status HIV positivo foi de 11,2%, demonstrando uma pequena redução progressiva de 5% desde 2011. Em 2017, a oferta de terapia antirretroviral e medicação anti-TB aos pacientes coinfectados por TB/HIV foi de 60%. Somente um terço das pessoas que vivem com HIV teve acesso à terapia preventiva com isoniazida. A mortalidade geral na coorte coinfectada por TB/HIV não mudou desde 2012, oscilando em torno de 20%. Conclusões. As atividades colaborativas para TB/HIV, que são a espinha dorsal para combater esta coinfecção, estão sendo ampliadas na ALC, e alguns indicadores mostram uma tendência positiva; no entanto, a nossa revisão destaca a necessidade de continuar fortalecendo a integração da prestação de serviços, as atividades conjuntas de monitoramento e avaliação e a qualidade dos dados.(AU)

Assessment of metals mobility during the alkaline treatment of highly acid phosphogypsum leachates.

This research evaluates the feasibility of an alkaline treatment system for highly acid leachates from a phosphogypsum stack located in an estuarine environment degraded by such pollution. The presented methodology consists of the addition of a Ca(OH)2 solution to the different types of phosphogypsum-related acidic leachates with the aim to increase their pH and subsequently, to provoke the precipitation and immobilization of the dissolved contaminants. In fact, phosphates and fluorides reached removal of 100% and 90%, respectively. As regards metals, removal values close to 100% were reached for Fe, Al, Cr, Cd, U and Zn, whereas it did not seem to be totally effective for other elements such as As (removal of 57-82%) and Sb (4-36%). The decrease of contaminant concentrations was caused probably by co-precipitation and/or adsorption to phosphate phases, together with by fluoride precipitation. The solid phases formed during the treatment were subjected to two standard leaching tests (EN 12457-2 from the EU and TCLP from the US) in order to conduct a risk and management assessment. In this context, some of the precipitates formed during the treatment would be classified as hazardous wastes, due to the high concentration of As leached. Moreover, the potential economic costs of a convectional active treatment system were also explored. This study sets the basis for a new research line with the aim to minimise the impact of the phosphogypsum stacks worldwide to their adjacent environment.

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.

PURPOSE: This multicenter phase II trial evaluated lurbinectedin (PM01183), a selective inhibitor of active transcription of protein-coding genes, in patients with metastatic breast cancer. A unicenter translational substudy assessed potential mechanisms of lurbinectedin resistance. PATIENTS AND METHODS: Two arms were evaluated according to germline BRCA1/2 status: BRCA1/2 mutated (arm A; n = 54) and unselected ( BRCA1/2 wild-type or unknown status; arm B; n = 35). Lurbinectedin starting dose was a 7-mg flat dose and later, 3.5 mg/m2 in arm A. The primary end point was objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST). The translational substudy of resistance mechanisms included exome sequencing (n = 13) and in vivo experiments with patient-derived xenografts (n = 11) from BRCA1/2-mutated tumors. RESULTS: ORR was 41% (95% CI, 28% to 55%) in arm A and 9% (95% CI, 2% to 24%) in arm B. In arm A, median progression-free survival was 4.6 months (95% CI, 3.0 to 6.0 months), and median overall survival was 20.0 months (95% CI, 11.8 to 26.6 months). Patients with BRCA2 mutations showed an ORR of 61%, median progression-free survival of 5.9 months, and median overall survival of 26.6 months. The safety profile improved with lurbinectedin dose adjustment to body surface area. The most common nonhematologic adverse events seen at 3.5 mg/m2 were nausea (74%; grade 3, 5%) and fatigue (74%; grade 3, 21%). Neutropenia was the most common severe hematologic adverse event (grade 3, 47%; grade 4, 10%). Exome sequencing showed mutations in genes related to the nucleotide excision repair pathway in four of seven tumors at primary or acquired resistance and in one patient with short-term stable disease. In vivo, sensitivity to cisplatin and lurbinectedin was evidenced in lurbinectedin-resistant (one of two) and cisplatin-resistant (two of three) patient-derived xenografts. CONCLUSION: Lurbinectedin showed noteworthy activity in patients with BRCA1/2 mutations. Response and survival was notable in those with BRCA2 mutations. Additional clinical development in this subset of patients with metastatic breast cancer is warranted.

Mobility of rare earth elements, yttrium and scandium from a phosphogypsum stack: Environmental and economic implications.

This paper investigates the mobility and fluxes of REE, Y and Sc under weathering conditions from an anomalously metal-rich phosphogypsum stack in SW Spain. The interactions of the phosphogypsum stack with rainfall and organic matter-rich solutions, simulating the weathering processes observed due to its location on salt-marshes, were simulated by leaching tests (e.g. EN 12457-2 and TCLP). Despite the high concentration of REE, Y and Sc contained in the phosphogypsum stack, their mobility during the leaching tests was very low; <0.66% and 1.8% of the total content of these elements were released during both tests. Chemical and mineralogical evidences suggest that phosphate minerals may act as sources of REE and Y in the phosphogypsum stack while fluoride minerals may act as sinks, controlling their mobility. REE fractionation processes were identified in the phosphogypsum stack; a depletion of LREE in the saturated zone was identified due probably to the dissolution of secondary LREE phosphates previously formed during apatite dissolution in the industrial process. Thus, the vadose zone of the stack would preserve the original REE signature of phosphate rocks. On the other hand, an enrichment of MREE in relation to HREE of edge outflows is observed due to the higher influence of estuarine waters on the leaching process of the phosphogypsum stack. Despite the low mobility of REE, Y and Sc in the phosphogypsum, around 104kg/yr of REE and 40kg/yr of Y and Sc are released from the stack to the estuary, which may imply an environmental concern. The information obtained in this study could be used to optimize extraction methods aimed to recover REE, Y and Sc from phosphogypsum, mitigating the pollution to the environment.

Morbidity, outcomes and cost-benefit analysis of wildlife rehabilitation in Catalonia (Spain).

BACKGROUND: There are few studies of careful examination of wildlife casualties in Wildlife Rehabilitation Centers. These studies are essential for detecting menaces to wild species and providing objective criteria about cost-benefit of treatments in those centers. The release rate is considered the main outcome indicator, but other parameters such as length of stay at the center and a cost-benefit index expressed as number of released animals per euro and day, could be used as reliable estimators of the rehabilitation costs. METHODOLOGY: A retrospective study based on 54772 admissions recorded from 1995-2013 in the database of the Wildlife Rehabilitation Center of Torreferrussa (Catalonia, NW Spain) assessed the morbidity, outcomes and cost-benefits of the rehabilitation practices. RESULTS: Three hundred and two species were included: 232 birds (n = 48633), 37 mammals (n = 3293), 20 reptiles (n = 2705) and 13 amphibians (n = 141). The most frequent causes of admission were: 39.8% confiscation of protected species (89.4% passerines), 31.8% orphaned young animals (35.3% swifts, 21.7% diurnal raptors and owls) and 17.4% trauma casualties (46.7% raptors and owls). The highest proportion of releases was found in the captivity confiscation category [87.4% passerines (median time of stay: 12 days)], followed by the orphaned category [78% owls (66 days), 76.5% diurnal birds of prey (43 days), 75.6% hedgehogs (49 days), 52.7% swifts (19 days) and 52% bats (55 days)]. For the trauma group, 46.8% of releases were hedgehogs (44 days) and 25.6% owls (103 days). As regards the cost-benefit index, the trauma casualties and infectious diseases had the worse values with 1.3 and 1.4 released animals/euro/day respectively, and were particularly low in raptors, waders, marine birds and chiroptera. On the contrary, captivity (4.6) and misplacement (4.1) had the best index, particulary in amphibian, reptiles and passerines. CONCLUSIONS/SIGNIFICANCE: Cost-benefit studies including the release rate, the time of stay at the center and the cost-benefit index should be implemented for improving management efficiency of the Wildlife Rehabilitation Centers.

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.

Mandatory tuberculosis (TB) notification is an important policy under the End TB Strategy, but little is known about its enforcement especially in high TB incidence countries. We undertook a literature search for selected high-incidence countries, followed by a questionnaire-based survey among key informants in countries with high-, intermediate- and low-TB incidence. Published literature on TB notification in high-incidence countries was limited, but it did illustrate some of the current barriers to notification and the importance of electronic systems to facilitate reporting by private providers. Required survey data were successfully gathered from 40 out of 54 countries contacted. TB is notifiable in 11 out of 15 high-incidence countries, all 16 intermediate-incidence countries, and all nine low-incidence countries contacted. TB case notification by public sector facilities is generally systematised, but few high-incidence countries had systems and tools to facilitate notification from private care providers. In the context of the new End TB Strategy aimed at eventual TB elimination, all countries should have TB on their national list of notifiable diseases. Enhancing the ease of notification by private providers is essential for effective implementation. To that effect, investing in strengthening disease surveillance systems and introducing digital tools to simplify notification are logical ways forward.

Assessment of compost maturity by using an electronic nose.

The composting process produces and emits hundreds of different gases. Volatile organic compounds (VOCs) can provide information about progress of composting process. This paper is focused on the qualitative and quantitative relationships between compost age, as sign of compost maturity, electronic-nose (e-nose) patterns and composition of compost and composting gas at an industrial scale plant. Gas and compost samples were taken at different depths from composting windrows of different ages. Temperature, classical chemical parameters, O2, CO, combustible gases, VOCs and e-nose profiles were determined and related using principal component analysis (PCA). Factor analysis carried out to a data set including compost physical-chemical properties, pile pore gas composition and composting time led to few factors, each one grouping together standard composting parameters in an easy to understand way. PCA obtained from e-nose profiles allowed the classifying of piles, their aerobic-anaerobic condition, and a rough estimation of the composting time. That would allow for immediate and in-situ assessment of compost quality and maturity by using an on-line e-nose. The e-nose patterns required only 3-4 sensor signals to account for a great percentage (97-98%) of data variance. The achieved patterns both from compost (chemical analysis) and gas (e-nose analysis) samples are robust despite the high variability in feedstock characteristics (3 different materials), composting conditions and long composting time. GC-MS chromatograms supported the patterns.

Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study.

The PANCOSTABRAX study evaluated the cost-effectiveness of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine (GEM) versus GEM alone in the treatment of patients with metastatic pancreatic cancer in Spain. Efficacy data were obtained from the MPACT study and were modeled to a lifetime horizon using a Markov model. The analysis was performed from the payer's perspective. Use of resources and key assumptions of the analysis were validated by a panel of oncologists. The addition of nab-paclitaxel to GEM showed higher effectiveness results (0.156 additional quality adjusted life years) at a higher cost (€6,477), resulting in a cost per quality-adjusted life years gained of €41,519. The combination of nab-paclitaxel and GEM has been shown to be an effective and well-tolerated option for the treatment of metastatic pancreatic cancer and, in addition to becoming the new standard of care, could also be considered a cost-effective option.

Prognostic indicators associated with early mortality of wild raptors admitted to a wildlife rehabilitation centre in Spain.

BACKGROUND: Assessment of the prognostic indicators of wildlife casualties is critical in wildlife rehabilitation practice, to optimize the use of economical resources, and to protect animal welfare. Few studies have been conducted in this field. OBJECTIVE: To identify the prognostic indicators associated with raptor mortality during the first week of hospitalization. ANIMALS AND METHODS: Complete medical records of 1722 wild raptor cases admitted to a wildlife rehabilitation centre from 1995 to 2007 were used. Regression models were created to determine mortality-related factors for different variables (order, sex, body condition (BC), clinical signs, and available haematological and biochemical parameters). RESULTS: In the bivariate analysis, the presence of nervous (OR = 11.9, 95%CI:5.1-27.6) or musculoskeletal (OR = 12.1, 95%CI:5.8-25.3) signs, a poor BC (OR = 32.9, 95%CI:19-81.2), and low values of packed cell volume (PCV), haemoglobin or total solids (TS), were all associated with early mortality. After adjusting variables in the multivariate model, BC was excluded due to co-linearity with other variables, and alteration of the nervous system was the only significant risk factor (OR = 4.0; 95%CI:1.9-8.8). In species specific analysis, poor prognosis was related to neurological signs in Athene noctua, poor BC in Strix aluco, trauma in Acciptiter nisus and Tyto alba, low PCV in Buteo buteo and Falco tinnunculus and low TS in Falco tinnunculus. CONCLUSIONS: Raptors with a poor BC, low values of PCV and those presenting with neurological signs, had the highest risk of dying in the first days of admittance. Thus, either medical care or humane euthanasia for poor prognosis should be performed to address animal welfare.

Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain.

AIM: The COSTABRAX study evaluated the cost-effectiveness of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) versus polyethylated castor oil-based standard paclitaxel (sb-paclitaxel) in the treatment of patients with previously treated metastatic breast cancer in Spain. MATERIALS & METHODS: Efficacy data were obtained from the CA012 trial (nab-paclitaxel administered every 3 weeks [q3w] and sb-paclitaxel q3w) and indirect comparison (sb-paclitaxel administered weekly), and were modeled to a time horizon of 5 years using a Markov model. The analysis was performed from the National Health Service perspective. Use of resources and key assumptions of the model were validated by a panel of 22 local oncologists. RESULTS: Compared with sb-paclitaxel q3w, nab-paclitaxel q3w was cost effective, with a cost per life year gained of €11,088 and a cost per quality-adjusted life year of €17,808. Compared with sb-paclitaxel administered weekly, it showed savings of €711 per patient. CONCLUSION: The COSTABRAX study showed that nab-paclitaxel q3w is a cost-effective alternative compared with sb-paclitaxel q3w and a cost-saving alternative to sb-paclitaxel administered weekly in Spain.

Assessment of phosphogypsum impact on the salt-marshes of the Tinto river (SW Spain): role of natural attenuation processes.

About 120 Mton of phosphogypsum from the fertiliser industry were stack-piled on the salt-marshes of the Tinto river (Spain). This paper investigates the capacity of salt-marshes to attenuate contamination due to downward leaching from phosphogypsum. Solids and pore-waters were characterized at different depths of the pile to reach the marsh-ground. In superficial zones, metals were highly mobile, and no reduced sulphur was found. However, pollutant concentration decreased in the pore-water in deeper oxygen-restricted zones. Metal removal occurred by precipitation of newly formed sulphides, being this process main responsible for the contamination attenuation. Pyrite-S was the main sulphide component (up to 2528 mg/kg) and occurred as framboids, leading to high degrees of pyritization (up to 97%). The sulphidization reaction is Fe-limited; however, excess of acid-volatile sulphide over other metals cause precipitation of other sulphides, mainly of Cu and As. This decrease in metal mobility significantly minimises the impact of phosphogypsums on the salt-marshes.